reducing clinical trial timelines and costs. Headquartered in Boston with R&D operations in Israel, YonaLink is bringing new levels of speed, quality, and efficiency to clinical trial operations ...
Clinical trial timelines continue to lengthen, particularly in Phase III (up 12%). Capital allocation strategies should continue to emphasize investment in early-stage innovation to help foster a ...
Q4 2024 Management View CEO Punit Dhillon highlighted significant progress with the clinical development of nimacimab, including the completion of patient enrollment for the CBeyond Phase IIa trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback